Basilea Pharmaceutica AG (SWX:BSLN)
53.50
+0.30 (0.56%)
Apr 28, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 189 employees as of December 31, 2025. The number of employees increased by 25 or 15.24% compared to the previous year.
Employees
189
Change (1Y)
25
Growth (1Y)
15.24%
Revenue / Employee
1.23M CHF
Profits / Employee
212.91K CHF
Market Cap
653.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Newron Pharmaceuticals | 27 |
| Santhera Pharmaceuticals Holding AG | 79 |
| BioVersys AG | 33 |
| Molecular Partners AG | 134 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Basilea Pharmaceutica AG News
- 13 days ago - Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting - GlobeNewsWire
- 19 days ago - Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 - GlobeNewsWire
- 5 weeks ago - Basilea announces start of first‑in‑human study of novel antibiotic BAL2420 - GlobeNewsWire
- 2 months ago - Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam - GlobeNewsWire
- 2 months ago - Basilea Pharmaceutica AG Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance - GlobeNewsWire
- 2 months ago - Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea - GlobeNewsWire
- 3 months ago - Basilea provides portfolio update and outlook - GlobeNewsWire